Physician

Antonio Loccisano, DO

According to 2025 Medicare claims, Antonio Loccisano, DO (NPI: 1508363243) practices sports medicine in the Camden, NJ market, with the plurality of this provider's patient population coming from Burlington, NJ. This provider's primary affiliated billing organization is VIRTUA MEDICAL GROUP, PA (NPI: 1649226515; TIN: 271348772) and primary practice location at 08055-9501.

Loccisano's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 491 traditional Medicare patients, billed 3,237 HCPCS/CPT codes, and received $122,947 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 305 prescription claims across 229 beneficiaries totaling $2,558 in drug costs, led by Naproxen (Naproxen). Open Payments data shows 3 records totaling $187. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$61K$123K2023 Medicare payment: $32,120 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $122,947 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023162823$32,120
20244913,237$122,947

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.7K$7.5K2018 Drug cost: $2,994 (USD; Tot_Drug_Cst)2019 Drug cost: $3,456 (USD; Tot_Drug_Cst)2020 Drug cost: $7,487 (USD; Tot_Drug_Cst)2021 Drug cost: $2,048 (USD; Tot_Drug_Cst)2022 Drug cost: $1,903 (USD; Tot_Drug_Cst)2023 Drug cost: $2,210 (USD; Tot_Drug_Cst)2024 Drug cost: $2,558 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R23$2,994
20192464$3,456
20202375$7,487
20211342$2,048
20221320$1,903
20234777$2,210
2024229305$2,558

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more198221$105
20611Aspiration and/or injection of fluid large joint using ultrasound guidance175225$86
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more282397$74
20610Aspiration and/or injection of fluid from large joint118198$59
J3301Injection, triamcinolone acetonide, not otherwise specified, 10 mg2661,592$1

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
NaproxenNaproxen1243,916$1,356
MethylprednisoloneMethylprednisolone59354$415
PrednisonePrednisone50601$152
IbuprofenIbuprofen15399$128
MeloxicamMeloxicam22644$78

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$187NeuroLogica Corporation, a subsidiary of Samsung Electronics Co., Ltd.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Antonio Loccisano, DO?

Tedicare shows public-source Medicare data for Antonio Loccisano, DO (NPI 1508363243), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Antonio Loccisano, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Antonio Loccisano, DO?

Antonio Loccisano, DO is linked to VIRTUA MEDICAL GROUP, PA (billing NPI 1649226515) in the available physician profile data.

Does Antonio Loccisano, DO have Open Payments data?

Antonio Loccisano, DO has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.